3D high-content analysis: An emerging solution for drug discovery
Learn about Olympus’ new solution for 3D high-content analysis and how patient-derived organoids can be utilized for more effective drug candidate profiling
Learn about Olympus’ new solution for 3D high-content analysis and how patient-derived organoids can be utilized for more effective drug candidate profiling
Dr. John Connolly, CSO of Tessa Therapeutics, reveals how a new approach to cell-based therapy in cancer could circumvent severe immunotherapy side effects and effectively target aggressive solid tumors
Learn about the development of a new Zika vaccine at the Instituto Butantan and key technology for maintaining consistency in immunobiological product production
The U.S. Food and Drug Administration has approved Inrebic (fedratinib) capsules to treat adult patients with certain types of myelofibrosis
Roche's assay to be used to find patients eligible for treatment with Tecentriq in combination with Abraxane
Long, high-yield oligos with low error rate enable researchers to skip amplification steps and start projects immediately
Approval marks the second drug approved under the Limited Population Pathway for Antibacterial and Antifungal Drugs and signals FDA’s continued focus on facilitating development of new treatments to fight antimicrobial resistant infections
First collaboration product includes medical imaging capabilities to enable more personalized treatment decisions in cancer care
The cobas TV/MG test promises to provide the flexibility to process up to four sexually transmitted infections from one patient sample
Download this application note from Sartorius to improve your moisture analysis results
The MicroScan WalkAway family of instruments was presented with the award for the second year in a row
The VENTANA ROS1 (SP384) rabbit monoclonal primary antibody is designed to effectively identify elevated ROS1 protein expression
Abbott's AlinIQ Integrated Platform analyzes currently siloed datasets to help hospitals make more informed decisions based on their unique needs
Join our webinar on Wednesday, September 4, for an overview of Quality by Design approaches to analytical method development
Discover an optimized, integrated workflow in our upcoming webinar for biopharmaceutical and biotech scientists
The acquisition of Toronto Research Chemicals brings wide breadth of synthetic and analytical chemistry capabilities
Get up to date on hot topics in the drug discovery community in our latest monthly compilation of content highlights
Zymo Research receives a record-breaking four trophies in the latest awards recognizing the laboratory products scientists love the most
Join this upcoming webinar to learn a simplified method for identifying unknown particles with Raman spectroscopy and LIBS
Agreement will address limitations in development of multiplex point-of-care Lateral Flow Assay diagnostic tests
Powerful and affordable liquid handling enhances hands-free throughput and reproducibility
Developed to enable the reliable, consistent and scalable application of cryo-electron microscopy to protein research and drug discovery
Rigaku is showcasing its newest X-ray analytical technology at M&M 2019